Homocystéine et risque cardiovasculaire: de l'utilité du dosage [Homocystein and cardiovascular risk: is dosage useful?]


Autoria(s): Mathez C.h.; Trueb L.; Darioli R.; Waeber G.
Data(s)

2004

Resumo

Hyperhomocysteinemia represents an independent risk factor for atherothrombotic disease. Physiopathological mechanisms of accelerated progression of atherosclerosis in presence of hyperhomocysteinemia are complex. Herein we report a clinical case which emphasis the importance of screening elevated homocystein in the absence of conventional risk factors in patients who suffer from premature atherosclerosis.

Identificador

http://serval.unil.ch/?id=serval:BIB_D7A7DA52B686

isbn:1661-8157

pmid:15646676

Idioma(s)

fr

Fonte

Praxis, vol. 93, no. 50, pp. 2093-7

Palavras-Chave #Adult; Coronary Artery Disease; DNA Mutational Analysis; Heterozygote Detection; Homocysteine; Humans; Male; Methylenetetrahydrofolate Reductase (NADPH2); Myocardial Infarction; Protein S Deficiency; Prothrombin; Recurrence; Risk Factors; Thrombophilia
Tipo

info:eu-repo/semantics/article

article